ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,307.89
-0.04%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Synaptogenix Inc (SNPX) Share Price

SNPX Synaptogenix Inc

4.17
0.00 (0.00%)
08 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Synaptogenix Inc NASDAQ:SNPX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 4.17 3.05 4.20 4.20 3.8908 4.13 28,542 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -13.78M -0.6757 -6.17 85.03M
 Type  Size  Price  Time  Units 
 13 6 4.11 20:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SNPX News
15/05/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202414:00PRNUSSynaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery
24/04/202414:15PRNUSSynaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
09/04/202414:15PRNUSSynaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics
03/04/202413:00PRNUSSynaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing
06/02/202415:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
21/12/202322:00EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for SNPX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Synaptogenix Inc Articles